abnormal gluconeogenesis, abnormal hair cycle, abnormal hair cycle anagen phase, abnormal hair follicle matrix region morphology, abnormal knee joint morphology, abnormal lens fiber morphology, abnormal ligament morphology, abnormal lipid homeostasis, abnormal lipid level, abnormal locomotor activation, abnormal locomotor circadian rhythm, abnormal nitric oxide homeostasis, abnormal pancreatic beta cell physiology, abnormal protein level, abnormal response to injury, abnormal sleep pattern, abnormal tail movements, abnormal vascular smooth muscle physiology, abnormal venous thrombosis, abnormal vertebral column morphology, arrhythmic circadian behavior persistence, behavior/neurological phenotype, calcified calcaneal tendon, calcified joint, calcified tendon, corneal epithelium hyperplasia, decreased IgG1 level, decreased abdominal adipose tissue amount, decreased body size, decreased circulating VLDL triglyceride level, decreased circulating adrenaline level, decreased circulating glucose level, decreased circulating noradrenaline level, decreased circulating progesterone level, decreased follicular B cell number, decreased heart weight, decreased insulin secretion, decreased kidney weight, decreased locomotor activity, decreased lung weight, decreased mean systemic arterial blood pressure, decreased muscle weight, decreased pancreatic islet number, decreased plasma anion gap, decreased prothrombin time, decreased spleen weight, decreased susceptibility to diet-induced obesity, decreased testis weight, decreased transitional stage B cell number, decreased uterus weight, decreased vasodilation, decreased white fat cell size, delayed circadian behavior phase, delayed parturition, early parturition, ectopic bone, failure of embryo implantation, fragmentation of sleep/wake states, hematopoietic system phenotype, homeostasis/metabolism phenotype, hypercoagulability, impaired leukocyte tethering or rolling, impaired righting response, impaired wound healing, increased circulating alanine transaminase level, increased circulating aspartate transaminase level, increased circulating factor VIII level, increased circulating fibrinogen level, increased circulating osteocalcin level, increased incidence of corneal inflammation, increased insulin sensitivity, increased liver triglyceride level, increased neutrophil cell number, increased osteoblast cell number, increased partial thromboplastin time, increased respiratory quotient, increased sebum secretion, increased susceptibility to induced thrombosis, increased total fat pad weight, increased triglyceride level, increased vasoconstriction, liver/biliary system phenotype, muscle phenotype, premature aging, premature death, prolonged estrous cycle, retarded hair growth, sacral vertebral fusion, shortened circadian behavior period, skeleton phenotype, small seminal vesicle, vascular smooth muscle hyperplasia, vision/eye phenotype